✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Veracyte Inc

Common Name
Veracyte
Country
United States
Sector
Healthcare
Industry
Diagnostics & Research
Employees
824
Ticker
VCYT
Exchange
NASDAQ/NMS
Description
Veracyte Inc. is a genomic diagnostics company specializing in advanced molecular diagnostic tests that address critical healthcare needs. The primary function of Veracyte is to improve patient outcom...

Veracyte's GHG Emissions Data Preview

In 2023, Veracyte completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Veracyte has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202320222021
2020 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
Limited Data Preview
You are viewing a limited preview of Veracyte’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2023, and revenue-based intensity metrics for each scope.
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=VCYT&reporting_period=2024"

Verified Sources Behind Veracyte’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Veracyte’s data sources below and access millions more through our Disclosure Search.

a. Veracyte's ESG Report 2024

Insights into Veracyte's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Veracyte amounted to 1,127 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Veracyte's Scope 1 Emissions Over Time

20230150300450600tCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Veracyte's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Veracyte were 448 metric tons of CO₂ equivalent (tCO₂e).a

What are Veracyte's Scope 2 emissions?

In 2023, Veracyte reported Scope 2 greenhouse gas (GHG) emissions of 679 tCO₂e without specifying the calculation method.a

What methodology does Veracyte use for Scope 2 reporting?

In 2023, Veracyte reported its Scope 2 emissions using an unspecified methodology.a

Veracyte's Scope 2 Emissions Over Time

20230200400600800tCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Veracyte’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Veracyte reported Scope 1 greenhouse gas (GHG) emissions of 448 tCO₂e and total revenues of USD 361 millions. This translates into an emissions intensity of 1.24 tCO₂e per millions USD.a

Veracyte's Scope 1 Emissions Intensity Compared to Peers

2502,00050,0001,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)RTCIQVIA HoldingsYear: 2023Scope 1: 8,221 tCO2eRevenue: $M 14,983Scope 1 Intensity: 0.55 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MExact SciencesYear: 2024Scope 1: 12,121 tCO2eRevenue: $M 2,759Scope 1 Intensity: 4.39 tCO2e/$MDanaherYear: 2024Scope 1: 109,046 tCO2eRevenue: $M 23,875Scope 1 Intensity: 4.57 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MMettler-Toledo InternationalYear: 2024Scope 1: 27,797 tCO2eRevenue: $M 3,872Scope 1 Intensity: 7.18 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MGuardant HealthYear: 2023Scope 1: 1,659 tCO2eRevenue: $M 564Scope 1 Intensity: 2.94 tCO2e/$MIlluminaYear: 2024Scope 1: 18,836 tCO2eRevenue: $M 4,372Scope 1 Intensity: 4.31 tCO2e/$MAgilent TechnologiesYear: 2024Scope 1: 29,698 tCO2eRevenue: $M 6,510Scope 1 Intensity: 4.56 tCO2e/$MMerit Medical SystemsYear: 2024Scope 1: 2,875 tCO2eRevenue: $M 1,357Scope 1 Intensity: 2.12 tCO2e/$MQuest DiagnosticsYear: 2024Scope 1: 111,724 tCO2eRevenue: $M 9,872Scope 1 Intensity: 11.32 tCO2e/$MWatersYear: 2023Scope 1: 12,660 tCO2eRevenue: $M 2,956Scope 1 Intensity: 4.28 tCO2e/$MSotera HealthYear: 2023Scope 1: 39,206 tCO2eRevenue: $M 1,049Scope 1 Intensity: 37.36 tCO2e/$MThermo Fisher ScientificYear: 2024Scope 1: 315,843 tCO2eRevenue: $M 42,879Scope 1 Intensity: 7.37 tCO2e/$MRRRevvityYear: 2024Scope 1: 2,468 tCO2eRevenue: $M 2,755Scope 1 Intensity: 0.90 tCO2e/$MTTTwist BioscienceYear: 2024Scope 1: 7 tCO2eRevenue: $M 313Scope 1 Intensity: 0.02 tCO2e/$MCharles River LaboratoriesYear: 2023Scope 1: 85,723 tCO2eRevenue: $M 4,129Scope 1 Intensity: 20.76 tCO2e/$MRepligenYear: 2023Scope 1: 2,236 tCO2eRevenue: $M 632Scope 1 Intensity: 3.54 tCO2e/$MIDEXX LaboratoriesYear: 2024Scope 1: 18,461 tCO2eRevenue: $M 3,898Scope 1 Intensity: 4.74 tCO2e/$MCCCatalyst PharmaceuticalsYear: 2024Scope 1: 4 tCO2eRevenue: $M 493Scope 1 Intensity: 0.01 tCO2e/$MNateraYear: 2024Scope 1: 5,143 tCO2eRevenue: $M 1,697Scope 1 Intensity: 3.03 tCO2e/$MVeracyteYear: 2023Scope 1: 448 tCO2eRevenue: $M 361Scope 1 Intensity: 1.24 tCO2e/$M

How does Veracyte's GHG emissions intensity compare to its peers?

In 2023, Veracyte reported a Scope 1 emissions intensity of 1.24 tCO₂e per millions USD. Compared to the peer group median of 3.54, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Veracyte rank on GHG emissions intensity within its industry?

In 2023, Veracyte ranked 7 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Veracyte is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Veracyte's GHG Emissions Dataset?
Sign Up